Former Genentech employee cuts plea deal with FBI in trade secrets case
Allergan says rivals using trade secrets disclosed by USITC order
canbedone / shutterstock.com
Amid confusion over patent eligibility, US life sciences IP owners should consider trade secret law when building their IP protection strategy, argues John A Stone of DeCotiis, FitzPatrick, Cole & Giblin.
Over the past decade, three high-profile US Supreme Court decisions—known by their shorthand names as Alice, Mayo, and Myriad—have generated significant uncertainty over what is and isn’t patentable.
This has made US trade secret law an increasingly valuable tool for protecting IP. Uncertainty around patent eligibility reduces investment and related innovation, and inhibits medical research advances. Protecting IP as trade secrets can also foster joint ventures, such as those between startups that create the IP and more established companies that can mass-produce, market and distribute the products.
As a result, companies often use trade secrets in tandem with, or instead of, patents to protect their IP. Given the role that life science and biotech IP can play in healthcare, increased use of trade secret protection in these sectors benefits society as a whole, as well as individual industries and companies.
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
European Patent Office
George Washington Law School
Kirkland & Ellis International LLP
Marks & Clerk
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
The United States Patent and Trademark Office (USPTO)
World Intellectual Property Office
For multi-user price options, or to check if your company has an existing subscription we can add you into for FREE, please contact Atif at firstname.lastname@example.org.
If you have any technical issues please email tech support.
Trade secrets, life sciences, IP, patents, DNA, Supreme Court, Myriad, DSTA, UTSA, biotechnology, Congress, USPTO